Poultry

Poultry
The trademarks indicated by CAPITAL LETTERS in this publication are the property of, licensed to, promoted or distributed by Schering-Plough Corporation, its subsidiaries or related companies. As used in this publication, the terms “Schering-Plough” and the “company” refer collectively to Schering-Plough Corporation, the publicly held parent company, and its domestic and international subsidiaries, which are engaged in the discovery, development, manufacturing and marketing of pharmaceutical, animal health and consumer products worldwide.

What's New?

Intervet / Schering Plough Animal Health at VIV Europe in Moscow

For the first time and before a large audience, Intervet / Schering Plough Animal Health will be presented as new combined company.

We offer you two attractive seminars.


Read more!



INNOVAX™ successfully launched in the US

INNOVAX™, the new innovative family of vaccines to aid in the prevention of very virulent Mareks disease, Newcastle disease and infectious laryngotracheitis (ILT), were launched successfully at the 144th American Veterinary Medicine Association (AVMA) annual convention in Washington D.C., in July 2007.


DateDescription
10 June 2009Intervet/Schering-Plough Animal Health's new INNOVAX poultry vaccine range now available in Latin AmericaBOXMEER (the Netherlands), June 10, 2009 — Intervet/Schering-Plough Animal Health, the global leader in animal health solutions, announces today that its innovative recombinant INNOVAX® poultry vaccine ...
7 April 2009Dieter Lütticken Award 2008 recognizes development of new vaccine quality control assayBOXMEER (the Netherlands), April 7, 2009 — Intervet/Schering-Plough Animal Health today announces that the Dieter Lütticken Award 2008 for alternatives in animal testing goes to Dr. Ivo Claassen for a ...
11 March 2009Intervet/Schering-Plough Animal Health sponsors peer-reviewed website on chicken anemia virusA peer-reviewed website about chicken infectious anemia has been launched under the sponsorship of Intervet/Schering-Plough Animal Health. The website — www.chicken-anemia.com — is intended to give poultry ...
29 January 2009Intervet/Schering-Plough Animal Health to focus on four areas of poultry-disease managementIntervet/Schering-Plough Animal Health has segmented its poultry-product line into four areas — food safety, immune-system defense, intestinal health and respiratory protection — to help focus its resources ...
29 January 2009Intervet/Schering-Plough Animal Health names global, regional support teams for poultryATLANTA, GA (USA) and BOXMEER (The Netherlands), January 29, 2009 — Intervet/Schering-Plough Animal Health has announced the following appointments for its Global Poultry Business Unit:• Dr. Marcelo Lang ...
27 January 2009Intervet/Schering-Plough Animal Health opens manufacturing facility for innovative poultry vaccine technologyDutch minister of Agriculture, Nature and Food Quality, Mrs. Gerda Verburg, visits animal health headquarters in Boxmeer and opens SPHEREON® facilityBOXMEER (The Netherlands), January 27, 2009 – Intervet/Schering-Plough ...
28 May 2008Intervet/Schering-Plough Animal Health appoints Heads of Global Species teams for swine, poultry and aquacultureBOXMEER (the Netherlands), May 27, 2008 – Intervet/Schering-Plough Animal Health appointed the Heads of Global Species teams for the swine, the poultry and the aquaculture segment. These appointments ...
20 November 2007INNOVAX™ successfully launched in the USINNOVAX™, the new innovative family of vaccines to aid in the prevention of very virulent Mareks Disease, Newcastle Disease and Infectious Laryngotracheitis (ILT), were launched successfully at the American ...
11 May 2007Intervet's bird flu vaccine receives EU licenseIntervet, a leading animal health company, received approval for its bird flu (avian influenza) vaccine Nobilis® Influenza H7N1. As a result, Europe now has a licensed vaccine to protect birds against ...
29 January 2007Intervet opens new production facility for vaccinesIntervet, the world’s largest producer of vaccines for animals, will open a production facility for vaccines in Boxmeer, the Netherlands, today. This will strengthen Boxmeer’s position as Intervet’s largest ...
1 September 2006Intervet’s avian flu vaccine licensed for use in European UnionIntervet’s vaccine is based on a different strain (H5N2) than the current field strain (H5N1). Birds vaccinated with H5N2 form a different set of antibodies than those birds infected with H5N1. These ...
25 July 2006Citing Special Need, USDA Issues Conditional License for Poultry Industry’s First Vaccine for Necrotic EnteritisSchering-Plough Animal Health Now Field Testing Product in USSchering-Plough Animal Health Corporation has obtained a conditional license from the U.S. Department of Agriculture to begin field testing ...
12 June 2006Intervet develops prototype for mass application avian influenza vaccineA biotech breakthrough achieved by Akzo Nobel’s animal health business, Intervet, means that mass application of a dual vaccine against avian influenza and Newcastle Disease could be available in the ...
27 April 2006Intervet supplies German zoos with avian influenza vaccineOn initiative of several federal states, Germany has obtained the European Union’s permission to vaccinate birds in zoos against avian influenza. To show its commitment to the preservation and protection ...
29 March 2006Intervet supplies Avian Influenza vaccine from vaccine bank to government of IsraelOn Monday March 20, 2006 Intervet shipped 4 million doses of Nobilis Influenza (strain H5N2) into Israel out of its vaccine bank. After receipt of the emergency order the product has been shipped within ...
16 February 2006Intervet supplies Avian Influenza vaccine to French GovernmentYesterday the French Ministry of Agriculture announced the intention to vaccinate outdoor ducks against Avian Influenza in three western parts of France (Landes, Loire atlantique and Vendée). The French ...
15 December 2005Reducing animal testingClostridial bacteria produce toxins that cause a range of diseases in animals.  Vaccines against these diseases are often developed from the toxins themselves. The production of clostridial vaccines involves ...
21 November 2005Intervet to support European ZoosBoxmeer, 21 November 2005 - In October the European Commission published a decision permitting the vaccination of zoo birds against bird flu, under certain conditions. The Dutch Government received EU ...
25 July 2005Citing Special Need, USDA Issues Conditional License for Poultry Industry’s First Vaccine for Necrotic EnteritisSchering-Plough Animal Health Now Field Testing Product in USSchering-Plough Animal Health Corporation has obtained a conditional license from the U.S. Department of Agriculture to begin field testing ...
25 June 2005Modern technology for animal and consumer safety - Intervet InternationalWith growing concern, we all read about outbreaks of highly infectious animal diseases, such as Foot and Mouth. Usually, these outbreaks result in millions of animals being killed in order to keep the ...
23 October 2003Salenvac T vaccine spreads wings at VIVBoxmeer, September 1, 2003 - VIV 2003 is the first non-UK debut of Nobilis Salenvac T, Intervet’s salmonella vaccine that protects against both S.enteritidis and S.typhimurium, making it an important ...
1 April 2003Vaccination against Avian InfluenzaBoxmeer, March 27, 2003 - The outbreak of Avian Influenza (fowl plague) in the Netherlands has sparked an ongoing debate about vaccination as an additional measure to control this viral disease. In principle, ...
11 March 2003Background information on Avian Influenza outbreakBoxmeer, March 11, 2003 – On March 1, 2003, the Dutch government decided to place a ban on all transport and export of poultry and poultry related farming products following a suspicion of an avian influenza ...